 i
中文摘要 
 
本計畫完成新穎玻尿酸醱酵與清潔純化製程之開發。本計畫首要建立改善玻尿酸醱酵
效能的策略。有鑑於玻尿酸體積產率與比生長速率成正相關的趨勢，批次醱酵被認為是生
產玻尿酸的最佳醱酵策略。為了進一步提高批次醱酵的效能，減少醱酵槽更新所花費的時
間，本計畫發展以半連續式生產玻尿酸的醱酵方法。研究發現，半連續式醱酵的培養基置
換時機必須設定在對數增殖期末期。此外，以重複式操作可以使批次醱酵產率由 0.24 g L-1 
h-1 提高至 0.60 g L-1 h-1。欲進一步提高體積產率，可藉由使用濃縮培養基提高菌體濃度而達
成；然而，玻尿酸累積造成的高黏度必須從提高攪拌速率來克服。研究發現，混合時間可
以用以評估醱酵液均勻度，藉由攪拌維持混合時間在 30 s 以內，可以保持細胞生產玻尿酸
的能力不受影響。以超過濾回收玻尿酸首先遭遇的困難在於濃度極化，利用氣液兩項流動
產生的氣泡，可以減輕濾膜玻尿酸累積導致的濃度極化。以去離子水進行超過濾透析，可
以在玻尿酸溶液導電度降低時，產生鹽溶現象而析出蛋白質，純化結果可回收 87%的玻尿
酸，不純物含量不到 0.1% (g protein/g HA)。此方法可以把回收玻尿酸與去除蛋白質結合於
單一操作程序，有效地簡化分離程序。最後，本計畫成功地開發具有吸附玻尿酸功能的超
順磁性二氧化矽粒子，此粒子表面以四級銨改質，在 30°C、pH 4.0 下的最大吸附量為 0.28 
g HA/g particle。本計畫開發的清潔純化方法，不需要添加沈澱劑與有機溶劑可以大幅地降
低玻尿酸純化製程的生產成本。 
 
關鍵字：鏈球菌、玻尿酸、比生長速率、半連續式醱酵、超過濾、吸附、磁性二氧化矽 
 
 
 iii
目錄 
 
中文摘要........................................................................................................................................... i 
Abstract ............................................................................................................................................ii 
第一章 前言.................................................................................................................................... 1 
第二章 玻尿酸批次醱酵生產效能之提升.................................................................................... 4 
2.1 研究背景與目的............................................................................................................... 4 
2.2 研究方法........................................................................................................................... 4 
2.2-1 菌株與培養基....................................................................................................... 4 
2.2-2 批次醱酵............................................................................................................... 5 
2.2-3 半連續式醱酵....................................................................................................... 5 
2.2-4 分析方法............................................................................................................... 5 
2.3 比生長速率對玻尿酸產率之影響................................................................................... 6 
2.4 以半連續式醱酵生產玻尿酸........................................................................................... 7 
2.5 高菌體濃度醱酵生產玻尿酸........................................................................................... 9 
2.6 結論................................................................................................................................. 11 
第三章 玻尿酸純化新穎製程...................................................................................................... 12 
3.1 研究背景與目的............................................................................................................. 12 
3.2 研究方法......................................................................................................................... 12 
3.2-1 超過濾操作......................................................................................................... 12 
3.2-2 超過濾透析......................................................................................................... 13 
3.2-3 磁性吸附載體之合成......................................................................................... 13 
3.2-4 分析方法............................................................................................................. 13 
3.3 以超過濾回收玻尿酸..................................................................................................... 14 
3.4 以超過濾透析回收玻尿酸............................................................................................. 17 
3.5 以吸附法回收玻尿酸..................................................................................................... 18 
3.6 結論................................................................................................................................. 19 
參考文獻........................................................................................................................................ 21 
計畫成果自評................................................................................................................................ 23 
可供推廣之研發成果資料表(1) ................................................................................................... 24 
可供推廣之研發成果資料表(2) ................................................................................................... 25 
 
 
 2
也提供了玻尿酸醱酵製程放大設計的準則。 
設計醱酵程序必須先了解微生物代謝物質屬於一次代謝產物，或是二次代謝產物。本
研究由顯微鏡觀察得知：鏈球菌在對數增值期，細胞外圍有明顯的莢膜，但進入停滯期之
後，莢膜將逐漸脫落(Fig. 1-2)，由此觀之玻尿酸係屬於一次代謝產物。對於一次代謝產物
而言，釐清比生長速率對產物生產之影響，乃是設計醱酵策略的重要關鍵。如果玻尿酸的
產量或產率與比生長速率有關，則可選擇饋料批次或連續式培養控制細胞的比生長速率，
讓鏈球菌在最適比生長速率下生產玻尿酸；如果比生長速率對鏈球菌生產玻尿酸的效率沒
有顯著的影響，批次醱酵即是最佳的醱酵方法。 
 
(a) 3 h (b) 5 h (c) 7 h 
   
(d) 8 h (e) 9 h (f) 10 h 
   
Fig. 1-2 在不同生長期下，鏈球菌型態與莢膜變化。(細胞於第 9 h 進入停滯期)。 
 
玻尿酸成品的價格取決於純度，事實上量產玻尿酸的瓶頸即主要在於純化程序的放
大。傳統上，玻尿酸的回收是利用長鏈烷基陽離子化合物容易與陰離子型高分子形成錯合
物的特性(此機制稱為 complex coacervation)，添加四級銨(quaternary ammonium)化合物，例
如氯化十六烷基砒啶 (cetylpyridium chloride, CPC) 或是溴化十六烷基三甲基銨
(hexadecyltrimethylammonium bromide, CTAB)作為沈澱劑，得到 HA-四級銨錯合物沈澱
(Cleland and Sherblom, 1977)，將沈澱物溶解於氯化鈉水溶液，可使錯合物解離(Lago et al., 
2005)，再加入 3 倍體積的醇類則可得玻尿酸沈澱物，此時即可移除溶解於上清液的四級銨
(Brown et al., 1994; Nimrod et al., 1988; Radaeva et al., 1997)，沈澱物可再藉由管柱層析或反
覆醇類沈澱處理提高玻尿酸純度。上述回收過程需要耗費大量醇類，不論從操作成本或是
工安的角度來考量，純化程序仍有很大的改善空間。 
薄膜分離技術是純化玻尿酸的另一選擇(Elllwood et al., 1996; Prescott, 2002)，但這些專
利僅利用超過濾回收玻尿酸並去除小分子物質，並沒有將薄膜分離技術的功能完全發揮。
Zhou 等人(2006)提出的改善方法是以微過濾(microfiltration, MF)與超過濾(ultrafiltration, UF)
所組合之兩階段掃流(tangential flow)程序純化玻尿酸，並分別使用 0.45 μm 的 MF 膜以及
MWCO 100 kD 的 UF 膜，在適當的操作條件下可回收 77%的玻尿酸，純化倍數則為 1000。 
以超過濾回收醱酵產物的主要困難在於需要克服過濾速率下降，濾速下降的原因來自
濃度極化(concentration polarization)以及薄膜結垢現象(membrane fouling)，濃度極化致使薄
膜表面處化學勢增加，薄膜表面的反向滲透壓增加，且當溶質濃度達到飽和濃度時，容易
 4
第二章 玻尿酸批次醱酵生產效能之提升 
 
2.1 研究背景與目的 
 
本研究首先以饋料批次操作改變 S. zooepidemicus ATCC 39920 細胞比生長速率，討論
比生長速率對玻尿酸生產的效應，實驗結果如 Fig. 3-1 所示，在相同的溫度下，玻尿酸的比
產率(Yp/x)與鏈球菌比生長速率關聯性並不高。由此可以推論，批次醱酵乃是醱酵生產玻尿
酸的最佳醱酵模式。然而，批次醱酵每次操作後需要耗費時間在處理請洗設備、管線滅菌
與培養基備料，無形中降低了醱酵設備的利用率。為了提高玻尿酸產率，本研究在第一年
的工作中建立以半連續式醱酵生產玻尿酸的操作方法，同時探討半連續式醱酵操作的限制
與改良策略。 
 
 
 
 
 
 
 
 
Fig. 3-1 比生長速率對玻尿酸比產率之影響(▲, 30°C; ■, 33°C; ●, 37°C)。 
 
一般而言，高菌體濃度醱酵是提高批次操作體積產率最直接的方式，但對於多醣類的
高黏度醱酵系統來說，多醣產物濃度的增加將提高醱酵液黏度，降低氧氣與養分的質傳阻
力，因而往往無法維持細胞生產產物的能力，亦即比產率反而隨養分濃度提高而下降。為
了滿足產程開發的需求，探討高菌體濃度醱酵生產玻尿酸的方法以及放大設計參數，是建
立玻尿酸製程不可或缺的研究工作。 
 
2.2 研究方法 
 
2.2-1 菌株與培養基 
 
本研究計畫所使用之菌株為 Streptococcus zooepidemicus ATCC 39920，購買自食品工
業發展研究所。Tryptic Soy Broth (TSB 培養基，成分見 Table 2-1)用於菌種保存以及前培養，
醱酵實驗之培養基成分如 Table 2-2 所示。 
Specific growth rate (h-1)
0.0 0.1 0.2 0.3 0.4
Sp
ec
ifi
c 
pr
od
uc
tiv
ity
 Y
P/
X 
(g
 H
A
/g
 c
el
l)
0.0
0.2
0.4
0.6
0.8
1.0
 6
儀測其濁度。對照菌體乾菌重檢量線，即可求出菌體濃度(g dry cell mass/L)。玻尿酸濃度測
定將根據 carbazole 法(Bitter and Muir, 1962)。葡萄糖濃度將採用還原糖法(Miller, 1959)測定
之。混合時間(mixing time)之估計是加入鹽酸，產生一個脈衝變化，並以 pH 計量測 pH 回
復至起始值 10%範圍時所需要之時間，作為混合時間之定義。 
 
2.3 比生長速率對玻尿酸產率之影響 
 
藉由饋料批次醱酵可以改變鏈球菌比生長速率，觀察比生長速率對玻尿酸生產之影響
(Fig. 2-2)。研究發現，在同一溫度下，玻尿酸比產率不受比生長速率改變而有明顯差異，
但在 30-37°C 之間，玻尿酸之比產率隨著溫度下降而增加，可以得知溫度為影響鏈球菌生
產玻尿酸能力之主要原因，而不是比生長速率。從醱酵實驗數據整理進一步發現，玻尿酸
體積產率隨著比生長速率增加而提高(Fig. 2-3)；可以預期，批次醱酵乃是醱酵生產玻尿酸
的最佳醱酵模式。有鑑於此，本計畫首先發展以半連續式生產玻尿酸的醱酵方法，並探討
半連續式醱酵之操作條件與限制。 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2-2 Effect of specific growth rate on HA fermentation.  Symbols: closed 
diamonds: μ = 0.58 h-1; closed circles: μ = 0.32 h-1, closed squares: μ = 0.19 
h-1; closed triangles: μ = 0.01 h-1.  Open symbols in panel (a) represent 
residual glucose in the fermentation broth. 
D
ry
 c
el
l m
as
s (
g 
ce
ll)
0
1
2
3
4
5
R
es
id
ua
l g
lu
co
se
 (g
)
0
5
10
15
20
Feeding start
Time (h)
0 4 8 12 16 20 24 28
H
ya
lu
ro
ni
c 
ac
id
 (g
 H
A
)
0
1
2
3
4
5
Feeding start
(a)
(b)
 8
如果把置換時機提前 1 小時，亦即對數增殖期末期，則可發現(Fig. 2-5)在置換次數在
6次以內，菌體濃度與玻尿酸的生產能力均能回復到置換前的水準，此時的體積產率為 0.105 
g HA L-1 h-1。如果提高置換體積為工作體積之 2/3，菌體濃度與玻尿酸的生產能力仍能回復
到置換前的水準，此時的體積產率為 0.059 g HA L-1 h-1 (Fig. 2-6)。 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2-5 Fill-and-draw culture of S. zooepidemicus with an exchange of 500 ml of 
medium starting at the late exponential growth phase. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2-6 Fill-and-draw culture of S. zooepidemicus with an exchange of 1000 ml of 
medium starting at the late exponential growth phase. 
C
el
l c
on
ce
nt
ra
tio
n 
(g
/ l)
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
Time (h)
0 2 4 6 8 10 12 14 16 18
H
A
 y
ie
ld
 (g
/ l)
0.0
0.5
1.0
1.5
2.0
C
el
l c
on
ce
nt
ra
tio
n 
(g
/ l)
0.0
0.5
1.0
1.5
2.0
2.5
3.0
Time (h)
0 4 8 12 16 20 24 28
H
A
 y
ie
ld
 (g
/ l)
0.0
0.5
1.0
1.5
2.0
 10
間大於 30 s 以上，即使細胞最高濃度不受影響，但是鏈球菌生產玻尿酸的能力卻明顯地隨
混合時間增加而下降。換言之，混和時間 30 s 可以作為一個放大參數，若要在濃縮倍率更
高的培養基下生產玻尿酸，必須提高攪拌速率，使醱酵槽的混合時間維持在 30 s 以內。 
 
Table 3-1 Effect of tryptone/yeast extract ratio on HA production. 
Round Tryptone 
(g/L) 
Yeast extract 
(g/L) 
DCW* 
(g/L) 
μm# 
(h-1) 
HA yield 
(g/L) 
Yp/x 
(g HA/g cell)
1 1.7 10.0 3.00 0.60 1.88 0.63 
2 10.0 1.7 2.49 0.70 1.90 0.76 
3 10.0 5.0 2.89 0.77 2.04 0.71 
4 7.1 3.4 2.82 0.68 1.76 0.62 
5 11.5 2.6 2.47 0.66 2.23 0.90 
6 11.5 0.9 1.78 0.73 2.35 1.28 
7 12.9 1.7 2.31 0.63 2.35 1.02 
* DCW: The maximum cell concentration in terms of dry cell weight. 
# μm: The maximum specific growth rate. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3-8 Effect of mixing time on HA production in the two-fold 
enriched fermentation medium. 
 
C
el
l c
on
ce
nt
ra
tio
n 
(g
/L
)
H
A
 y
ie
ld
 (g
/L
)
0
1
2
3
4
5
Working vol.: 1.5 L, 300 rpm with gate impeller
Working vol.: 1.5 L, 500 rpm with two turbines
Working vol.: 1.5 L, 300 rpm with gate impeller
Working vol.: 1.0 L, 400 rpm with one turbine
Working vol.: 1.5 L, 400 rpm with two turbines
Mixing time (s)
0 20 40 60 80 100 120 140 160
Y P
/X
 (g
 H
A
/g
 c
el
l)
1.0
1.2
1.4
1.6
1.8
HA yield
Cell conc.
30 s
 12
第三章 玻尿酸純化新穎製程 
 
3.1 研究背景與目的 
 
根據薄膜孔洞大小，薄膜分離可分成：(1)微過濾，孔徑介於 0.1-10 μm；(2)超過濾，
孔徑介於 2-100 nm (3)逆滲透，孔徑小於 2 nm。操作方式可區分為：濾餅過濾(cake filtration)
以及掃流過濾(crossflow filtration or tangential flow filtration)。濾餅過濾是讓流體垂直通過濾
膜，而得到濾出液(permeate)；隨著過濾程序的進行，濾膜表面累積的溶質愈來愈多，產生
的濃度極化現象，將明顯地降低過濾通量(flux)，過濾難以長時間操作。在掃流過濾的操作
模式下，流體流動的方向與濾膜平行，因此，流體流動產生的剪應力可以減緩濃度極化現
象，延長操作時間。 
利用超過濾可以自醱酵液直接回收產物，免除沈澱濃縮的步驟，並可移除大部分蛋白
質，然而，即使以掃流方式操作，仍然無法避免濃度極化現象。有鑑於此，本單元的成果
將首先介紹以兩相流動，降低濃度極化現象，提高濾液通量的超過濾操作模式；其次說明
以超過濾透析，分離玻尿酸與蛋白質的操作程序。 
其次，玻尿酸為陰離子型高分子，可與四級銨分子形成錯合物而沈澱(Fig. 3-1)，離子
交換樹脂，也有吸附效果(Fig. 3-1)。若能在吸附載體表面改質，接上四級銨官能基，預期
會有良好的吸附效果，有機會開發成純化玻尿酸的量產方法。有鑑於此，本計畫將在第二
年的工作增加微奈米粒子合成與表面改質的研究，製備表面具備四級銨官能基的磁性二氧
化矽粒子，並探討以磁性粒子吸附回收玻尿酸的方法。 
 
 
 
 
 
Fig. 3-1 SEM images of hyalrurinic acid (HA) recovered by cetyl pyridium 
chloride (CPC) and ion-exchangers. (a) Precipitates of HA-CPC 
complex; (b) Adsorption of HA on the ion-exchangers A. (c) 
Adsorption of HA on the ion-exchangers B. 
 
3.2 研究方法 
 
3.2-1 超過濾操作 
 
過濾裝置使用 100 kDa MWCO 的過濾膜，過濾面積為 63.65 cm2，模組內渠道高度為
0.5 cm。超過濾系統裝置如 Fig. 3-2 所示，操作步驟為： 
(a) (b) (c)
 14
 
 
 
 
 
 
 
 
 
 
 
  Fig. 3-3 Reaction route of surface modification on magnetic silica particles. 
 
3.3 以超過濾回收玻尿酸 
 
醱酵產物玻尿酸之分子量為 1,100 kDa，於是先採用 100 kDa 的超過濾膜，直接回收於
醱酵液中的玻尿酸。實驗操作條件控制在壓力為 10 psi、液相流速為 75 ml/min。從 Table 3-1
可以看出：在 pH 6.8 下，有 12%的玻尿酸可通過 100 kDa 的濾膜，100 kDa 的濾膜無法完
全回收 1,100 kDa 的玻尿酸分子之原因可能在於玻尿酸為一線性高分子，在超過濾操作下，
容易被拉伸成線性，因而通過 100 kDa 的濾膜。為了減少玻尿酸的損失，本研究將醱酵液
pH 調整為 2.5，以便增加玻尿酸分子間作用力，彼此之間較為聚集而形成一較為剛性的高
分子。超過濾回收的實驗結果發現，在 pH 2.5 的條件下玻尿酸的損失約只有 4%，但殘留
在濾膜的玻尿酸卻增加了，亦即濃度極化效應較為明顯。 
 
Table 3-1 Effect of pH on the recovery of hyaluronic acid 
pH HA (g) Filtrate Recovered Fouled Loss 
6.8 0.42 0.056 g 0.21 g 0.16 g 12% 
2.5 0.42 0.004 g 0.19 g 0.22 g 4% 
 
兩相流動過濾系統可藉由注入空氣造成邊界層擾動，降低濃度極化現象；氣液兩相流
體接觸產生的氣泡的大小與穩定將影響邊界層擾動程度。如Fig. 3-4所示，箭頭指向為流體
流動方向。操作條件為：透膜壓力30 psi、液相流速35 ml/min、氣相流速30 ml/min、注入因
子為0.46。然而實驗發現導入的空氣易受到管壁的阻礙，而降低氣體的流速，且渠道的寬
度為1.2 cm，高度為0.5 cm，但注入空氣與醱酵液的管徑卻只有0.3 cm，相形之下，氣泡更
顯微小，不易壓縮邊界層。因此，利用空氣向上的浮力、及液體向下之重力，可使得導入
模組的氣泡可以壓縮邊界層；於是在將同的操作條件下，將模組旋轉45°及180°。結果發現
 16
有提高。 
固定注入因子，同時增加氣液兩相的流速的實驗結果顯示於Fig. 3-7。比較不同氣液流
速以及單相流動超過濾，發現固定注入因子而同時提高氣液兩相流速，濾速並沒有因此而
有顯著的增加。觀察此時的氣泡型態，若液相流速75 mL/min，氣相流速65 mL/min，此時
氣泡大約形成直徑0.5 cm的大小，均勻且分散於整個模組內，主要是因為氣泡是藉由液相
帶入模組，所以當液相流速增加，氣泡也會隨之快速進入模組，所以不容易聚集成較大顆
的氣泡型態；而液相流速35 mL/min，氣相流速30 mL/min，其氣泡則是以更大顆的子彈型
均勻分布於模組內。由此數據可更進一步證明：氣泡形態才是增進濾速的主因，並以形成
子彈型的Taylor bubble造成管壁的剪應力影響較大。 
 
 
 
 
 
 
 
 
 
 
Fig. 3-6 Effect of injection factor on permeate flux. Injection factor: 
(z)0; ({)0.22; (▼)0.36; (V)0.46. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3-7 Effect of gas flow rate on permeate flux. Symbol: ({) liquid flow rate = 
35 ml/min, without gas; (z) liquid flow rate = 75 ml/min, gas flow rate = 
65 ml/min; (▼) liquid flow rate = 35 ml/min, gas flow rate = 30 ml/min. 
 
Time (min)
0 20 40 60 80 100
J v
 (m
3 /m
2  h
)
0.002
0.004
0.006
0.008
0.010
0.012
0.014
0.016
0.018
Time (min)
0 20 40 60 80 100
J v
 (m
3 /m
2  h
)
0.004
0.006
0.008
0.010
0.012
0.014
0.016
0.018
 18
3.5 以吸附法回收玻尿酸 
 
利用共沈澱法合成之氧化鐵形貌如 Fig. 3-9 所示，由穿透式電子顯微鏡可以發現粒子
直徑約介於 10-20 nm，由電子繞射圖計算之面間距可確認合成之產物為 Fe3O4；由超導量
子干涉磁量儀(SQUID Magnetometer)量測其磁滯曲線(hysteresis curve)得知，產物屬於超順
磁性(superparamagnetic)材料。磁性二氧化矽奈米粒子影像如 Fig. 3-10 所示，可以清楚地看
出，Fe3O4 被二氧化矽所包覆，一個二氧化矽包覆數個 Fe3O4 粒子。 
 
 
 
 
 
 
Fig. 3-9 TEM image of the iron oxide nanoparticles 
 
 
 
 
 
 
Fig. 3-10 Image of magnetic silica particles. 
 
二氧化矽層的厚度可以藉由調整 TEOS 濃度而改變(Fig. 3-11)。本研究選擇直徑為 800 
nm 的磁性二氧化矽進行表面修飾改質，以不同溶劑進行 glycidyltrimethylammonium chloride 
(GAC)改質後材料表面之 FTIR 光譜顯示於 Fig. 3-12。由 C-N 鍵的吸收峰可初步判定改質成
功。 
 
 
 
 
 
 
 
 
Fig. 3-11 Effect of TEOS concentration on the particle size of magnetic silica. (a) 
TEOS, 0.12M; (b) TEOS 0.35M; (c) TEOS 0.58M; (d) TEOS 0.81M 
 20
製程。本單元中第一部份提出的氣液兩相流動操作方式，可以降低濃度極化現象，提高超
過濾的操作效能。第二部份討論的超過濾透析，可以同時回收玻尿酸並且移除大部分的蛋
白質。在第三部分的工作，成功地開發以四級銨表面修飾的磁性粒子回收玻尿酸， 
 
 
 22
15. Lee, C.K., Chang, W.G., and Ju, Y.H. (1993). Air slugs entrapped cross-flow filtration of 
bacterial suspensions. Biotechnol. Bioeng., 41, 525-530. 
16. Miller, G.L. (1959). Use of dinitrosalicyclic acid reagent for determination of reducing sugar. 
Anal. Chem. 31, 426-428. 
17. Nimrod, A., Greenman, B., Kanner, D., and Landsberg, M. (1988). High molecular weight 
sodium hyaluronate. US Patent 4,784,990. 
18. Nimrod, A., Greenman, B., Kanner, D., Landsberg, M., and Beck, Y. (1988). Method of 
producing high molecular weight sodium hyaluronate by fermentation of streptococcus. US 
Patent 4,780,414. 
19. Prescott, A. (2002). Method for purifying high molecular weight hyaluronic acid. US Patent 
6,660,853. 
20. Radaeva, I.F., Kostina, G.A., and Zmievskii, A.V. (1997). Hyaluronic acid: biological role, 
structure, synthesis, isolation, purification, and applications. Appl. Biochem. Microbiol. 33, 
111-115. 
21. Stöber, W., Fink, A., and Bohn, E. (1968). Controlled growth of monodisperse silica spheres. 
J. Colloid Interf. Sci. 26, 62-69. 
22. Um, M.J., Yoon, S.H., Lee, C.H., Chung, K.Y., and Kim, J.J. (2001). Flux enhancement with 
gas injection in crossflow ultrafiltration of oily wastewater. Wat. Res., 35, 4095-4101. 
23. van de Rijn, I., and Keessler, R. E. (1980). Growth characteristics of group A streptococci in 
a new chemically defined medium. Infect. Immun. 27, 444-448. 
24. Wang, H.-M., Li, C.-Y., Chen, S.-J., Cheng, T.-W., and Chen, T.-L. (2004). Abatement of 
concentration polarization in ultrafiltration using n-hexadecane/water two-phase flow. J. 
Membr. Sci. 238, 1-7. 
25. Zhou, H., Ni, J., Huang, W., and Zhang, J. (2006). Separation of hyaluronic acid from 
fermentation broth by tangential flow microfiltration and ultrafiltration. Sep. Purif. Technol. 
25, 29-38. 
26. 謝佩娟. (2009). 以四級銨官能基修飾之磁性奈米粒子之製備. 國立高雄應用科技大學化
學工程與材料工程系碩士論文. 
 
 
 
 24
可供推廣之研發成果資料表(1) 
 
□ 可申請專利  ■ 可技術移轉                                     日期：2010 年 1 月 30 日 
國科會補助計畫 
計畫名稱：玻尿酸批次醱酵與純化程序效能之提升 
計畫主持人：陳樹人 
計畫編號：NSC 96−2221−E−151−043−MY2 學門領域：化學工程
技術/創作名稱 高體積產率玻尿酸醱酵程序 
發明人/創作人 陳樹人、陳嘉凌、黃怡琳、鍾心怡 
本技術揭示提高獸疫鏈球菌批次醱酵生產玻尿酸的策略，在細胞生
長進入停滯期之前，抽出醱酵液並置換同體積的新鮮醱酵液，可以
重複地進行批次醱酵生產，體積產率最高可提高為批次醱酵的 2.5
倍。欲以高菌體濃度生產玻尿酸，可提高培養基基質濃度，並加快
攪拌速率，保持培養液的混合時間小於 30 s，便可確保醱酵液攪拌
的均勻度，並且維持細胞生產玻尿酸能力 
 
 
技術說明 
The improvement on batch production of hyaluronic acid (HA) 
production by Streptococcus zooepidemicus was disclosed.  HA 
production could be performed with a fill-and-draw culture starting by 
displacing the fermentation broth with fresh medium just before the 
stationary phase.  The maximum volumetric productivity was 2.5-fold 
compared with typical batch culture.  Production of HA in a 
high-cell-density culture could be performed using concentrated 
medium.  The mixing time (less than 30 s) is a critical point for 
ensuring the homogeneity of broth and maintaining the productivity of 
streptococcal cells. 
 
 
可利用之產業 
及 
可開發之產品 
可利用之產業：化學製藥業、化妝品製造業、食品產業 
可開發之產品：醫藥級玻尿酸、化妝品級玻尿酸 
技術特點 
1. 可利用現有醱酵設備系統生產，不需要另外添購生產設備。 
2. 可以提高典型批次生產產能至少 2.5 倍。 
推廣及運用的價值 
1. 新穎技術與方法，國內外沒有類似論文或專利發表。 
2. 放大設計的準則可應用於不同的醱酵設備系統。 
※ 1.每項研發成果請填寫一式二份，一份隨成果報告送繳本會，一份送 貴單位研
發成果推廣單位（如技術移轉中心）。 
※ 2.本項研發成果若尚未申請專利，請勿揭露可申請專利之主要內容。 
※ 3.本表若不敷使用，請自行影印使用。 
 
 1
出席國際學術會議心得報告(第一年) 
                                                             
計畫編號 NSC 96−2221−E−151−043−MY2 
計畫名稱 玻尿酸批次醱酵與純化程序效能之提升 
出國人員姓名 
服務機關及職稱 
陳樹人 
國立高雄應用科技大學化材系 助理教授 
會議時間地點 2007 年 11 月 20-22 日南韓首爾高麗大學(Korea University) 
會議名稱 The 13th Symposium of Young Asia Biochemical Engineers’ Community
發表論文題目 A Fermentation Strategy for Maintaining the Plasmid Stability in 
Recombinant Protein Production 
 
一、參加會議經過 
 
亞洲青年生化工程會議(YABEC)係於1995年由遠東地區臺灣、南韓、日本與中國
四個國家的生化工程學者共同發起，力排各種政治干擾，自1995年起在四個國家每年輪
流舉辦，至今已成為亞洲地區生化工程學術交流盛事，近年也有越南與印度學者開始參
與。第十三屆亞洲青年生化工程會議是由南韓化學工程學會生化工程分會(Division of 
Biochemical Engineering and Biotechnology, Korean Institute of Chemical Engineers)以及
高麗大學綠色化學工程研究所(Institute of Green Chemical Engineering System, Korea 
University)主辦，與會人數共有來自亞洲地區約200名學者代表參加。 
大會活動於11月21日上午8時50分開始，分別由大
會主席Moo Hwan Cho與地主代表Kwan Young Lee致
詞。大會演講由南韓先進科學技術院(KAIST) Jak-Sung 
Kim發表以計算生物方法進行酵素結構分析與功能改
善的研究趨勢。專題演講則依照往例，分別由四個地
區代表主講，第一場講題為「新穎薄膜程序在生化分
離程序之發展與應用」，由北京中國科學院萬印華教
授主講；第二場講題為「微生物轉麩醯胺酵素」，由
日本九洲大學神谷典穗教授發表；第三場講題為「多
功能奈米生物複合體」，由臺灣大學彭慶安教授主講；
第四場講題為「智慧奈米材料在生物醫學上之應用」，
由南韓生物科學與生物技術研究院 (KRIBB) Bong 
Hyun Chung教授主講。從各專題演講主題可以發現生
化工程的研究趨勢已自傳統的醱酵工程、酵素應用、
生化分離程序等領域擴展到分子與奈米科技，例如：
以生物資訊技術改良生物分子功能、開發與製備可應
 3
三、建議 
 
歷年來YABEC經費籌措不易，各地區參加的人數均有上限，不過國內仍有數位碩
博士生在國科會或指導教授的贊助下主動參加。整體來看國內碩博士生的語文溝通確實
進步很多，可見得國科會近年來推動的各項研究生參與國際交流補助已有明顯成效。略
為可惜的是，本次主辦單位沒有沿襲前一屆在義守大學(YABEC 2006)舉辦的議程，安
排各國博士生論文發表的場次。如果國內舉辦類似的國際學術研討會，在經費預算允許
下排定各國博士生論文發表的議程，邀請參與國家推薦年輕研究生參加，不僅能促進各
國研究生彼此觀摩與交流，更能國內激勵的碩博士生參與國際交流的勇氣；若能持續長
久推動，必能使國際年輕學者對臺灣留下深刻的印象，並鞏固臺灣在國際學術界的地位。 
 
 
 5
程研究所劉春朝博士主講。 
有別於傳統研討會的議程安排，主辦單位取消論文宣讀場次，並把壁報論文發表
分成兩個時段，現場壁報討論進行之前先舉行1小時的flash presentation，報告人在大會
演講廳台上，以30秒的時間簡要介紹研究成果，flash presentation結束後，再進行壁報
論文展示與討論。因此，與會者能夠快速地瀏覽每一篇論文，對參與人員的研究專長印
象比較深刻，也有較多的時間認識交流並交換研究心得。 
 
二、與會心得 
 
筆者在此次研討會發表的論文標題為：「Fermentation method for producing high 
concentration hyaluronic acid by Streptococcus zooepidemicus ATCC39920」。一般來說，
欲增加體積產率可以使用濃縮培養基提高菌體濃度而達成，然而玻尿酸生產是一個高黏
度的醱酵系統，玻尿酸比產率(YP/X)無法隨著菌體濃度之濃度提高而維持不變，亦即製
程放大設計受限於高黏度造成的養分與氧氣傳送質傳阻力，有必要尋找量化指標評估高
黏度醱酵系統的均勻性。有鑑於混合時間(mixing time)可以作為評估攪拌系統的參數，
本論文探討高濃度培養基系統下，混合時間對玻尿酸比產率(YP/X)與產率係數(YP/S)，研
究發現在高濃度培養基醱酵系統，提高攪拌速率是必要的，而且將混合時間控制在30 s
以下，即可以維持比產率與產率係數不變，顯示混合時間可以作為提高玻尿酸體積產率
的參數。 
和其他三國學者的交流，令人印象最深刻的是中國學者在醱酵與酵素應用的研究
量能，來自北京中國科學院、北京化工大學與華東理工大學的學者在產學合作的表現十
分積極，投入許多學生接受廠商委託開發的特用化學品醱酵產程。從這現象可看出製造
業的發展對科學技術研究的正面效應，在製造業蓬勃發展的助力下，學者得以獲得研究
靈感，構築新穎的基因重組微生物、利用廠商資金開發新穎的製程，加上充沛的人力支
援，中國學者在醱酵與酵素工程的論文數目已領先各國，我國學者只能在研究構想上尋
求優勢。 
從人才培育的角度思考，關心國內產業發展，由廠商需求尋找研究主題，不失為
培養符合企業需求人才的好方法。目前國內生技產業以健康食品與生醫器材為主力，參
加這次的研討會，使筆者體認積極主動接觸業者的重要性，在了解業者技術提昇的需求
之餘，多介紹生化與生醫工程的最新發展，洽詢合作開發新產品與技術的機會。 
 
三、建議 
 
參加國際研討會可以在極短的時間，觀摩不同的研究想法，對拓展學術視野的助
益很大，也可以看到各國科技政策的推動成果。與其他國家相比較，臺灣學者發表的論
文仍以小型研究團隊為主，國內學者宜加強合作交流，結合團隊力量從事新穎跨領域主
題的研究  
 
 7
Introduction 
 
The segregational instability of plasmids is often experienced in the production of 
foreign proteins by a recombinant Escherichia coli culture.  It is well known that plasmid 
replication and cell fission are not synchronous.  The uneven distribution of plasmids during 
cell fission may result in the formation of plasmid-free daughter cells.  Once the segregant 
cells are born, a competitive instability may appear owing to the growth advantage of 
plasmid-losing cells over plasmid-carrying cells, since the expression of plasmid-encoded 
genes imposes an extra metabolic burden on the host cell [1–4].  Consequently, in the 
absence of selective pressure, the plasmid-losing cells may quickly overwhelm the cell 
population. 
Many methods for maintaining the stability of plasmids in a recombinant culture have 
been suggested.  Typically, the introduction of the selective pressure provided by antibiotics 
is recognized as being capable of maintaining plasmid stability, although, in fact, the 
emergence of plasmid-losing cells is still inevitable, since the selective pressure may be 
relieved by antibiotics-degrading enzymes [5].  Additionally, the plasmid-carrying cells with 
low plasmid copy number might be damaged severely by antibiotics [6].  Moreover, cost 
considerations make this strategy unfavorable for large-scale operations.  Another selective 
pressure method is to cultivate an auxotrophic host that requires the plasmid to synthesize 
essential amino acids in an incomplete selective medium.  However, the plasmid-losing cells 
can still survive, because they can ingest the particular amino acid produced by 
plasmid-carrying cells [7].  In addition, several engineering approaches have also been 
proposed for preventing plasmid instability, including cell immobilization [8], cycling the 
dilution rate for delaying the washout of plasmid-carrying cells in a chemostat culture [9, 10], 
and selective recycling of plasmid-carrying cells [11].  The methods above involve 
 9
isopropyl-β-D-thiogalactopyranoside (IPTG), creatinase is secreted to the periplasm. 
The recombinant E. coli cells were maintained at –20°C in 50% (v/v) glycerol.  Prior 
to fermentation, the preculture was carried out in a 500-ml Erlenmeyer flask with a working 
volume of 100 mL.  The preculture medium containing (per liter): 10 g tryptone, 5 g yeast 
extract, 10 g NaCl, and 50 mg ampicillin was adjusted to pH 7.0 with NaOH.  After 
overnight incubation in a reciprocal shaker (120 rpm) at 37°C, the preculture broth was 
inoculated to the fermenter. 
The two-stage fermentations were performed in a 2.5 L fermenter (Model M-100, 
Tokyo Rikakikai, Japan), with a starting working volume of 1000 ml.  The medium used in 
the first-stage culture was R medium [13] whose composition is shown in Table 1.  After the 
cell growth entered the stationary phase, the second stage culture was carried out by adding 
400 mL of the fresh LB medium supplemented with IPTG to the fermenter for inducing the 
expression of the creatinase gene.  All fementations were conducted at 37°C and pH 7.0 
unless stated otherwise.  The dissolved oxygen was kept above 40% by changing aeration 
rate and agitation speed throughout the fermentation process.  If the second stage was 
performed with a fed-batch operation, IPTG with a desired concentration was first introduced 
to the broth.  The fresh LB medium containing the desired concentration of IPTG was then 
fed into the fermenter.  The feeding rate was 2 mL/min. 
 
 11
 
Results and Discussion 
 
1. Examination of the timing of plasmid segregation 
Traditionally, introducing antibiotics to the fermentation broth is the most common 
strategy for maintaining the plasmid stability in a recombinant culture.  However, our 
preliminary experiments (data not shown) showed that the addition of selective pressure 
(ampicillin) was not sufficient to ensure the stability of plasmids throughout the fermentation 
since ampicillin was degraded by the secretion of β-lactamase.  In addition, the creatinase 
yield obtained from the culture with antibiotics was comparable to that obtained from the 
culture without selective pressure.  Furthermore, when considering the cost of antibiotics, 
the effectiveness of maintaining plasmid stability by the addition of selective pressure is 
limited.  It is thus worth deducing a plasmid-maintaining strategy that operates without 
selective pressure. 
The timing of the decrease in plasmid stability was examined in a 1000-mL batch 
culture containing of two-fold concentrated LB medium (pH 6.0).  The inducer IPTG was 
introduced at the fermentation time of 2 h, corresponding to a cell concentration of 0.6 g/L.  
As shown in Fig. 1, after IPTG induction, the stability of plasmid dropped abruptly from 
100% to around 50% when the cell mass doubled from 0.6 g to around 1.2 g.  A further 
 13
g/L could be obtained from LB and R medium, respectively; thus, R medium is obviously 
more suitable for being a growth medium.  In addition, there were no plasmid-losing cells 
observed in the cultures without the inducer.  For investigating the creatinase production, 0.5 
mM IPTG was added to the fermentation broth at a cell concentration of 0.6 g/L.  It can be 
seen that the introduction of IPTG to R medium inhibited the growth of cells; however, the 
addition of IPTG to LB medium was beneficial to cell growth.  The stability of plasmid in 
the R medium culture was significantly lower than that in the LB medium culture, which 
might be due to multiple occurrences of cell fission in the R medium culture.  In addition, 
the specific creatinase yield obtained from LB medium was higher than that obtained from R 
medium, indicating that LB medium is more appropriate for enzyme production.  The 
decrease in the creatinase yield obtained from the R medium culture might be attributed to 
the instability of plasmids.  Thus, based on the characteristics of the media, R medium was 
used in the first stage as the growth medium and LB medium was used in the second stage as 
the producing medium. 
 
3. Plasmid maintenance in the two-stage culture 
The verification of our strategy is shown in Fig. 3.  In the first stage, the cells grew to 
a cell concentration of 12.5 g/L in the R medium with 27.5 g/L of glucose.  In the second 
stage, 400 ml of the 2-fold concentrated LB medium supplemented with IPTG was 
 15
metabolic burden imposed by the expression of creatinase gene. 
 
4. Plasmid maintenance in a fed-batch culture 
The production of recombinant protein is often performed in a fed-batch culture.  
Therefore, our strategy was further investigated using a fed-batch operation.  Fig. 5 shows 
that the cells were grown in the R medium with 27.5 g/L of glucose in the first stage.  The 
fed-batch culture began at the fermentation time of 11 h.  During the fed-batch stage, 400 
mL of 2-fold concentrated LB was fed with a flow rate of 2 mL/min and the concentration of 
IPTG in the fermentation broth was kept at 1.0 mM throughout.  During the creatinase 
producing phase, the cell mass in the fermenter increased from 12.9 to 14.3 g.  Since the 
doubling in cell mass was not attainable, it was expected that no plasmid-losing segregant 
would appear in the culture.  The results, shown in Fig. 5, agreed with our prediction. 
Based on our hypothesis, the plasmid-losing cells were expected to appear after the cell 
mass was doubled in a fed-batch production culture.  Therefore, the change of plasmid 
stability during creatinase production in a fed-batch culture was further examined.  As 
shown in Fig. 6, the cells in the growth phase were cultivated in the R medium with 3 g/L of 
glucose.  The fed-batch culture began at the fermentation time of 6 h.  Hereafter, 400 mL 
of 3-fold concentrated LB was fed with a flow rate of 2 mL/min and the concentration of 
IPTG in the fermentation broth was kept at 0.5 mM throughout the fed-batch stage.  In the 
 17
Taiwan (project No. KUAS-94-SB-001).
 19
Figure Legends 
 
Fig. 1 Time course analysis of the change of plasmid stability.  The cells were cultivated in 
the two-fold concentrated LB medium (pH 6.0).  IPTG with a final concentration of 
0.5 mM was added at the fermentation time of 2 h. 
 
Fig. 2 Cell growth and creatinase production in LB and R medium with or without IPTG.  
IPTG with a final concentration of 0.5 mM was added at the fermentation time of 2 h. 
 
Fig. 3 Plasmid stability and creatinase production in a two-stage culture.  In the first stage, 
the cells were cultivated in the R medium with 27.5 g/L of glucose.  In the second 
stage, two-fold concentrated LB medium with various concentration of IPTG was 
supplemented. 
 
Fig. 4 Plasmid loss during the enzyme producing stage after the doubling of the cell mass.  
In the first stage, the cells were cultivated in the R medium with 3 g/L of glucose.  In 
the second stage, three-fold concentrated LB medium with 0.5 mM of IPTG was 
supplemented to the fermenter. 
 
Fig. 5 Maintenance of plasmid stability in a fed-batch culture.  In the batch stage, the cells 
were cultivated in the R medium with 27.5 g/L of glucose.  In the fed-batch stage, 
two-fold concentrated LB medium was fed with a flow rate of 2 mL/min.  IPTG 
concentration was kept at 1.0 mM. 
 
Fig.6 Plasmid loss in a fed-batch culture.  In the batch stage, the cells were cultivated in 
the R medium with 3 g/L of glucose.  In the fed-batch stage, three-fold concentrated 
LB medium was fed with a flow rate of 2 mL/min.  IPTG concentration was kept at 
0.5 mM. 
 
 21
 
 
 
Time (h)
0 2 4 6 8 10
C
el
l c
on
ce
nt
ra
tio
n 
(g
/L
)
0
1
2
3
4
5
T
ot
al
 c
re
at
in
as
e 
yi
el
d 
(k
U
/L
)
0
2
4
6
8
10
12
14
16
18
20
Pl
as
m
id
 st
ab
ili
ty
 (%
)
0
20
40
60
80
100
Cell concentration
Total creatinase yield 
Plasmid stability 
IPTG
 
 
Fig. 1 Time course analysis of the change of plasmid stability.  The cells were cultivated in 
the two-fold concentrated LB medium (pH 6.0).  IPTG with a final concentration of 
0.5 mM was added at the fermentation time of 2 h. 
 23
C
el
l c
on
ce
nt
ra
tio
n 
(g
/L
)
0
2
4
6
8
10
12
14
16
18
Pl
as
m
id
 st
ab
ili
ty
 (%
)
0
20
40
60
80
100
IPTG 0.5 mM (cell concentration)
IPTG 1.0 mM (cell concentration)
IPTG 2.0 mM (cell concentration)
IPTG 0.5 mM (plasmid stability) 
IPTG 1.0 mM (plasmid stability) 
IPTG 2.0 mM (plasmid stability)
Time (h)
0 2 4 6 8 10 12 14 16 18
To
ta
l c
re
at
in
as
e 
yi
el
d 
(k
U
/L
)
0
5
10
15
20
25
30
Sp
ec
ifi
c 
cr
ea
tin
as
e 
yi
el
d 
(U
/g
 c
el
l)
0
1
2
3
4
5
IPTG 0.5 mM (total creatinase yield) 
IPTG 1.0 mM (total creatinase yield) 
IPTG 2.0 mM (total creatinase yield) 
IPTG 0.5 mM (specific creatinase yield) 
IPTG 1.0 mM (specific creatinase yield)
IPTG 2.0 mM (specific creatinase yield)
2xLB medium
with IPTG
 
Fig. 3 Plasmid stability and creatinase production in a two-stage culture.  In the first stage, 
the cells were cultivated in the R medium with 27.5 g/L of glucose.  In the second 
stage, two-fold concentrated LB medium with various concentration of IPTG was 
supplemented. 
 25
 
 
Time (h)
0 2 4 6 8 10 12 14 16 18
C
el
l c
on
ce
nt
ra
tio
n 
(g
/L
)
0
2
4
6
8
10
12
14
16
To
ta
l c
re
at
in
se
 y
ie
ld
 (k
U
/L
)
0
5
10
15
20
25
30
35
40
45
Sp
ec
ifi
c 
cr
ea
tin
as
e 
yi
el
d 
(k
U
/g
 c
el
l)
0
1
2
3
4
5
6
Pl
as
m
id
 st
ab
ili
ty
 (%
)
0
20
40
60
80
100 Cell concentration 
Total creatinase yield 
Specific creatinase yield 
Plasmid stability 
2xLB medium
with IPTG
Batch phase Fed-batch phase
 
Fig. 5 Maintenance of plasmid stability in a fed-batch culture.  In the batch stage, 
the cells were cultivated in the R medium with 27.5 g/L of glucose.  In the 
fed-batch stage, two-fold concentrated LB medium was fed with a flow rate 
of 2 mL/min.  IPTG concentration was kept at 1.0 mM. 
 
 27
出席國際學術會議發表論文(第二年) 
 
Fermentation Method for Producing High Concentration Hyaluronic Acid by 
Streptotoccsu zooepidemicus ATCC39920 
 
Shu-Jen Chen1*, Jia-Ming Yang2 and Wei-Chih Huang2 
1Department of Chemical and Materials Engineering, National Kaohsiung University of Applied 
Sciences, Kaohsiung 80778, Taiwan 
 2Department of Chemical Engineering, National Cheng Kung University, Tainan 70101, Taiwan 
*No.415 Chien Kung Road, Kaohsiung 80778, Taiwan; biochen@cc.kuas.edu.tw 
 
Hyaluronic acid (HA) is a high molecular weight glycosaminoglycan consisting of alternating 
D-glucuronic acid and N-acetylglucosamine, which are linked alternately by β(1→3) and β(1→4) 
glycosidic linkages.  HA is endowed with viscoelasticity, demonstrating high viscosity at low shear 
rates and shows high elasticity at high shear rates.  Owing to its distinct hydrodynamic properties, 
HA has been widely applied in the pharmaceutical and cosmetic industries.  Since microbial 
fermentation of HA is receiving increased attention, the increase in the productivity of HA is 
necessary for an economical fermentation process. 
Generally, medium composition is an influential factor on the product yield.  The optimal 
medium composition for producing HA was thus determined with the two-dimensional simplex 
algorithm, which resulted in a specific productivity of HA (YP/X) of 1.28 in a batch culture.  However, 
the obtained YP/X decreased to around 1.1 in a two-fold concentrated medium, indicating the 
productivity of HA could not be maintained in a nutrient-rich medium.  Namely, the production of 
high concentration HA in a batch culture is hard to attain, possibly because of the continuous 
increases in the viscosity of fermentation broth and gradual decrease in the availability of nutrients 
during the HA production.  Since the homogeneity of fermentation broth in an agitated fermenter can 
be evaluated by mixing time.  The effects of mixing time on the specific productivity of HA (YP/X) 
and yield coefficient of HA (YP/S) were examined in the concentrated media.  It was found that 
increasing agitation speed is necessary for maintaining the productivity of HA in a concentrated 
medium and the length of mixing time should be kept below 30 s.  Therefore, the high concentration 
HA could be produced in a batch culture where the agitation speed is altered in light of the viscosity 
of fermentation broth.  Additionally, the mixing time would be a criterion for scaling up HA 
fermentation. 
 
References 
1. Huang, W.-C., Chen, S.-J., and Chen, T.-L., “The role of dissolved oxygen and function of 
agitation in hyaluronic acid fermentation,” Biochem. Eng. J., 32, 239-243 (2006). 
